🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy

Recruitingn/aAges 18 Years - anyMaleLithuanian University of Health Sciences
NCT07516886 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective observational study aims to evaluate the prognostic significance of early postoperative prostate-specific antigen (PSA) levels in patients undergoing radical prostatectomy for prostate cancer. No investigational interventions will be performed. All diagnostic procedures, follow-up assessments, and treatments will be conducted in accordance with standard clinical practice and established prostate cancer management guidelines. Participation in the study will not influence treatment decisions.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient is an adult biological male. * Patient has morphologically confirmed and untreated prostate cancer. * Patient who will be treated with open, laparoscopic or robot-assisted laparoscopic radical prostatectomy. * Patient is informed about this observational study and has signed the informed consent form. Exclusion Criteria: * Patient has radiologically of morphologically confirmed prostate cancer metastases before the operation. * Patient received neoadjuvant prostate cancer treatment. * Patient is set to receive adjuvant treatment. * Patient has any contraindications for the operation.
💊

What it tests

  • Radical Prostatectomy
📍

Where

1 site
Lithuanian University of Health Sciences Hospital Kaunas Clinics, Department of Urology
Kaunas, Lithuania
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy